The Master of Translational Medicine (MTM) program links the Department of Bioengineering at Berkeley with the Department of Bioengineering and Therapeutic Sciences at UCSF and is designed to train students in applying translational research and engineering approaches to solve fundamental problems in healthcare delivery. The master’s program draws on the unique expertise and technological resources available at the two institutions to provide trainees with the tools necessary to address real-world problems in a creative, interdisciplinary team setting.
This program should appeal to engineers, scientists, and clinicians who seek to bring innovative treatments and devices into clinical use. Individuals with backgrounds in medicine, nursing, dentistry, and pharmacy are encouraged to apply. We anticipate that upon receiving their master’s degree or after further academic or clinical training, graduates will work in industries that deliver healthcare products or patient care.
Coursework includes translational aspects of therapeutic science and principles of engineering design. Content covers the fundamentals of bioengineering, physiology and disease processes, along with core medical principles, clinical research methods, and clinical trials design, as well as basics of business and management. The program culminates in a capstone design project experience in which students work in interdisciplinary teams co-advised by an engineering faculty member and an MD, PharmD, or clinician.
The MTM program is focused specifically on training in translational medicine as opposed to basic research science. As such, this master’s degree is generally intended as a terminal degree for students interested in industry and entrepreneurship and is not a gateway to the Bioengineering PhD program.
Source: Berkeley Academic Guide